Paul Burgess

Corporate Officer/Principal at CEREVEL THERAPEUTICS HOLDINGS, INC.

Net worth: - $ as of 30/05/2026

53 year

Health Technology

Consumer Services

Profile

Paul Burgess is Chief Business Development Officer at Cerevel Therapeutics Holdings, Inc. since 2023 and Chief Operating & Business Officer at Kailera Therapeutics, Inc. since 2024.
Former roles include Director-Intellectual Property at Logical Therapeutics, Inc., In-House Counsel at Johnson & Johnson, Vice President-Intellectual Property at DNIB Unwind, Inc. from 2008 to 2015, Secretary, Chief Operating & Legal Officer at Translate Bio, Inc. from 2019 to 2021, Head-Intellectual Property at Civitas Therapeutics, Inc. from 2011 to 2015, Vice President-Intellectual Property at Scholar Rock, Inc. from 2015 to 2016, and Head-Legal at TransForm Pharmaceuticals, Inc. Education includes an undergraduate degree from Merrimack College in 1995 and graduate degrees from Northeastern University in 1999 and 2002.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
-.--%	16/04/2026	0 ( -.--% )	- $	30/05/2026

Paul Burgess active positions

Companies	Position	Start
CEREVEL THERAPEUTICS HOLDINGS, INC.	Corporate Officer/Principal	19/06/2023

All active positions of Paul Burgess

Former positions of Paul Burgess

Companies	Position	End
TRANSLATE BIO, INC.	Chief Operating Officer	13/09/2021
Scholar Rock, Inc. Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company	Corporate Officer/Principal	31/03/2016
DNIB UNWIND INC	Corporate Officer/Principal	30/06/2015
Civitas Therapeutics, Inc. Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies	Corporate Officer/Principal	31/01/2015
TransForm Pharmaceuticals, Inc. TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs	General Counsel	-

See the detail of Paul Burgess's experience

Training of Paul Burgess

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Burgess's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Johnson & Johnson Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products	Health Technology
DNIB Unwind, Inc. DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations	Health Technology
Translate Bio, Inc. Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein	Health Technology
Merrimack College Merrimack College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Northeastern University Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
TransForm Pharmaceuticals, Inc. TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs	Health Technology
Logical Therapeutics, Inc. Logical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops products that treat diseases associated with inflammation	Health Technology
Civitas Therapeutics, Inc. Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies	Health Technology
Scholar Rock, Inc. Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company	Health Technology
Cerevel Therapeutics Holdings, Inc. Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders	Health Technology